Storage and handling
Sealed storage.
Sealed storage.
Sodium Lactate Ringer's Injection Instructions
Please read the instructions carefully and use under the guidance of a physician.
Check carefully before use. Do not use if leakage is found, the drug liquid is unclear, or there are visible particles.
This product is a compound preparation, its components are: sodium lactate 3.10g, sodium chloride 6.00g, potassium chloride 0.30g, calcium chloride (CaCl2·2H2O) 0.2g per 1000ml.
Excipient Name: Sodium Hydroxide
Osmotic Pressure Molar Concentration: 240-270mOsmol/kg
This product is a colorless and clear liquid.
Regulating body fluids, electrolytes and acid-base balance regulating drugs. For metabolic acidosis or dehydration cases with metabolic acidosis.
Intravenous drip. Adult 500ml ~ 1000ml at a time, according to age weight and symptoms can be appropriate to increase or decrease. Administration speed: 300 ~ 500ml per hour for adults.
The following conditions should be contraindicated:
The following cases should be used with caution:
The following tests and observations should be made during medication:
Pregnant women with gestational poisoning may aggravate edema, increase blood pressure, should be used with caution.
The dosage should be calculated according to age, weight and condition.
Elderly patients often have hidden cardiac and renal insufficiency, which should be used with caution.
When combined with other drugs, pay attention to the incompatibility of drugs (such as macrolide antibiotics, alkaloids, sulfonamides) due to changes in pH and ionic strength. Because this product contains calcium ions, it will precipitate when mixed with blood containing sodium citra
An overdose may result in edema or ion imbalance in the body.
This product can regulate body fluid volume and osmotic pressure, and can supplement potassium, sodium, calcium and chloride ions. Among them, sodium lactate is converted into bicarbonate ion in the body to regulate acid-base balance and maintain normal physiological functions; Na+is the most important cation in extracellular fluid, which is the main substance for maintaining constant osmotic pressure and extracellular volume of body fluid. K+is the main intracellular cation, which plays an important role in maintaining normal neuromuscular excitability. As a second messenger in the cell, calcium ion is closely related to many functions in the body. Lactate ions can correct metabolic acidosis and allow potassium ions to enter the cell from blood and extracellular fluid. When the amount of circulating blood and interstitial fluid in the body is reduced, this product can be used as a supplementary regulator of interstitial fluid, and has a corrective effect on electrolyte disturbance and acidosis.
This experiment has not been performed and no reliable references are available.
Sealed storage.
[Package]
Plastic infusion bag (non-PVC co-extruded film, double hard tube, easy to break apart , double valve and double plug). 500ml/ bag, 1000ml/ bag.
[Validity] 24 months
[Executive standard] Pharmacopoeia of the People's Republic of China (2020, Volume II)
[Pharmaceutical marketing authorization holder] Name: Huaren Pharmaceutical Co., Ltd. Registered Address: No. 187, Zhuzhou Road, Qingdao High-tech Park,China
[Manufacturer]
Enterprise Name: Huaren Pharmaceutical Co., Ltd.
Production Address: No. 187, Zhuzhou Road, Qingdao High-tech Park,China
Zip code: 266101
Tel.: 400-0648885 0532-67709071
Fax: 0532-88702625
Website:http//
www.qdhuaren.com
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85268-802 | 85268-802-02, 85268-802-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM CHLORIDE | M4I0D6VV5M | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| SODIUM LACTATE | TU7HW0W0QT | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 430669d7-9ad2-9a04-e063-6394a90ababb | 33881d79-9b8b-f9dc-e063-6394a90aba81 | 2025-11-07 | Adverse reactions | 33881d79-9b8b-f9dc-e063-6394a90aba81 |
Adverse event summaries are temporarily unavailable. Other product information remains available.